ARHGEF2 and colorectal carcinoma: Having demonstrated that YTHDF1-m6A-ARHGEF2 axis as a novel oncogenic signaling cascade in CRC, the authors constructed lipid nanoparticles (LNP) encapsulated with siRNA targeting ARHGEF2.